TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 56 filers reported holding TRANSMEDICS GROUP INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,142,139 | -29.7% | 477,482 | +7.8% | 2.84% | -20.7% |
| Q2 2023 | $37,198,269 | +2.7% | 442,942 | -7.4% | 3.58% | -10.0% |
| Q1 2023 | $36,205,528 | -6.4% | 478,087 | -23.7% | 3.98% | -14.2% |
| Q4 2022 | $38,675,603 | +15.2% | 626,630 | -22.1% | 4.64% | +13.4% |
| Q3 2022 | $33,566,000 | +19.1% | 804,180 | -10.2% | 4.09% | +11.1% |
| Q2 2022 | $28,178,000 | +204.4% | 895,962 | +160.7% | 3.68% | +298.3% |
| Q1 2022 | $9,258,000 | +198.6% | 343,661 | +112.4% | 0.92% | +231.5% |
| Q4 2021 | $3,100,000 | -43.1% | 161,819 | -1.8% | 0.28% | -40.9% |
| Q3 2021 | $5,451,000 | +168.0% | 164,753 | +53.9% | 0.47% | +78.1% |
| Q4 2019 | $2,034,000 | +1.0% | 107,045 | +26.2% | 0.26% | -18.2% |
| Q3 2019 | $2,013,000 | -20.8% | 84,792 | -3.3% | 0.32% | +2.2% |
| Q2 2019 | $2,541,000 | – | 87,683 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 923,221 | $30,632,000 | 5.64% |
| Sandhill Capital Partners LLC | 1,429,432 | $47,429,000 | 3.70% |
| Bullseye Asset Management LLC | 117,471 | $3,898,000 | 1.31% |
| Taylor Wealth Management Partners | 72,685 | $2,412,000 | 0.85% |
| Signature Wealth Management Partners, LLC | 14,000 | $465,000 | 0.42% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 369,259 | $12,252,000 | 0.40% |
| Triumph Capital Management | 20,051 | $622,000 | 0.36% |
| EMERALD ADVISERS, LLC | 300,464 | $9,969,000 | 0.36% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,347 | $2,533,000 | 0.30% |
| Bellevue Group AG | 729,989 | $24,221,000 | 0.24% |